Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Tailored digital support to cut sedentary time in long-term cardiac rehab

Official title: Effects of a Tailored Intervention With Digital Health Tools on Sedentary Behaviour and Health-related Physical Outcomes in Long-term Cardiac Rehabilitation Patients: a Randomized Controlled Trial

Run by University of Lisbon · NCT07910812 · Data updated 2026-11-12

In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment64 (estimated)
SponsorUniversity of Lisbon
Academic / other
Locations1 site (Lisbon, Lisbon District)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedAugust 31, 2027
Study endsDecember 31, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT07910812 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with stable cardiovascular disease enrolled in a long-term (phase III) cardiac rehabilitation program for at least 6 months and sedentary for more than 8 hours per day.

Probably not a fit

Individuals not owning a smartphone or unable to engage with digital prompts may derive less benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial evaluates a 6-month tailored behavioural intervention added to standard long-term cardiac rehabilitation. The intervention uses individualized counselling, digital prompts, smartphone self-monitoring, and educational resources to reduce sedentary behaviour. Primary outcome is objectively measured daily sedentary time with activPAL4. The study aims to determine if integrating digital health tools and tailored coaching can sustain lifestyle changes and improve cardiovascular-related health outcomes in this population.

Why it matters

Potential benefit: If successful, participants may experience less sedentary time and potential improvements in physical health and quality of life.

How similar studies have gone: Previous work suggests digital and behavioural approaches can reduce sedentary time in cardiovascular populations, though long-term CR-specific data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older
* Clinically stable
* Documented cardiovascular disease (CVD), including angiographically documented coronary artery disease involving at least one major epicardial vessel, previous myocardial infarction, previous coronary revascularization (percutaneous coronary intervention or coronary artery bypass grafting), heart failure (including cardiac transplantation), heart valve surgery or prosthetic valve/clip implantation, left ventricular assist devices, cardiac resynchronization therapy devices, implantable cardioverter-defibrillators, pacemakers, or congenital heart disease
* Enrolled in a long-term (phase III) cardiac rehabilitation (CR) programme for at least 6 months
* More than 8 hours per day of sedentary behaviour (SB), objectively assessed using activPAL4 during the baseline assessment

Exclusion Criteria:

* Unable or unwilling to provide written informed consent
* Do not own a smartphone compatible with the study digital health tools

Where it's running

  • Faculty of Medicine of the University of Lisbon
    Lisbon, Lisbon District, Portugal
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.